Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Helix Energy Solutions
HLX
$1.4B
| $5.78M | ﹤0.01% |
1,851,710
+80,377
| +5% | +$296K |
|
|
AAN
2277
DELISTED
The Aaron's Company Inc
AAN
| $5.78M | ﹤0.01% |
234,392
-15,215
| -6% | -$389K |
|
2278
ATN International
ATNI
$366M
| $5.78M | ﹤0.01% |
144,545
+9,840
| +7% | +$421K |
|
2279
Vaxcyte
PCVX
$7.81B
| $5.76M | ﹤0.01% |
242,319
+4,571
| +2% | +$106K |
|
2280
Keros Therapeutics
KROS
$199M
| $5.75M | ﹤0.01% |
98,336
-208
| -0.2% | -$10.4K |
|
|
ONL
2281
Orion Office REIT
ONL
$150M
| $5.74M | ﹤0.01% |
+307,167
| New | +$6.07M |
|
2282
Citi Trends
CTRN
$555M
| $5.73M | ﹤0.01% |
60,464
-22,417
| -27% | -$1.79M |
|
2283
Hyster-Yale Materials Handling
HY
$599M
| $5.72M | ﹤0.01% |
139,261
+11,652
| +9% | +$509K |
|
2284
Rackspace Technology
RXT
$1.05B
| $5.72M | ﹤0.01% |
424,534
+6,963
| +2% | +$99.6K |
|
2285
Columbia Financial
CLBK
$1.12B
| $5.71M | ﹤0.01% |
273,466
+2,683
| +1% | +$52K |
|
|
ABTX
2286
DELISTED
Allegiance Bancshares
ABTX
| $5.7M | ﹤0.01% |
134,994
+1,861
| +1% | +$76K |
|
2287
Artivion
AORT
$1.3B
| $5.7M | ﹤0.01% |
279,980
+10,417
| +4% | +$210K |
|
2288
IDT Corp
IDT
$1.64B
| $5.67M | ﹤0.01% |
128,479
+2,212
| +2% | +$112K |
|
2289
Replimune Group
REPL
$941M
| $5.66M | ﹤0.01% |
208,894
+3,638
| +2% | +$109K |
|
2290
Tucows
TCX
$172M
| $5.63M | ﹤0.01% |
67,117
+705
| +1% | +$59K |
|
2291
WIX.com
WIX
$2.3B
| $5.62M | ﹤0.01% |
35,613
+1,585
| +5% | +$275K |
|
|
CELL
2292
DELISTED
PhenomeX Inc. Common Stock
CELL
| $5.61M | ﹤0.01% |
308,519
+4,545
| +1% | +$98.1K |
|
2293
Peoples Bancorp
PEBO
$1.5B
| $5.61M | ﹤0.01% |
176,240
+5,274
| +3% | +$170K |
|
|
FBMS
2294
DELISTED
The First Bancshares, Inc.
FBMS
| $5.6M | ﹤0.01% |
145,003
+3,384
| +2% | +$135K |
|
2295
Portillo's
PTLO
$331M
| $5.6M | ﹤0.01% |
+149,146
| New | +$5.98M |
|
2296
Core & Main
CNM
$8.23B
| $5.6M | ﹤0.01% |
184,505
+10,205
| +6% | +$280K |
|
2297
Scorpio Tankers
STNG
$3.9B
| $5.6M | ﹤0.01% |
436,907
+30,257
| +7% | +$467K |
|
2298
Arcturus Therapeutics
ARCT
$164M
| $5.58M | ﹤0.01% |
150,847
+1,287
| +0.9% | +$52.4K |
|
2299
Amneal Pharmaceuticals
AMRX
$5.85B
| $5.57M | ﹤0.01% |
1,161,637
+15,374
| +1% | +$76.6K |
|
2300
Community Trust Bancorp
CTBI
$1.42B
| $5.56M | ﹤0.01% |
127,427
+13,265
| +12% | +$578K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.